Label: ACETIC ACID solution

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated April 24, 2020

If you are a consumer or patient please visit this version.

  • Rx only

  • DESCRIPTION

    Acetic acid otic solution, USP is a solution of acetic acid (2%), in a propylene glycol vehicle containing propylene glycol diacetate (3%), benzethonium chloride (0.02%), sodium acetate (0.015%), and citric acid. The molecular formula for acetic acid is CH3COOH, with a molecular weight of 60.05. The structural formula is:

    Chemical Structure

    Acetic acid otic solution, USP is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

  • CLINICAL PHARMACOLOGY

    Acetic acid is antibacterial and antifungal; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

  • INDICATIONS AND USAGE

    For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial.

  • CONTRAINDICATIONS

    Hypersensitivity to acetic acid otic solution or any of the ingredients. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

  • WARNINGS

    Discontinue promptly if sensitization or irritation occurs.

  • PRECAUTIONS

    Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

  • PEDIATRIC USE

    Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

  • ADVERSE REACTIONS

    Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

    To report SUSPECTED ADVERSE REACTIONS, contact Saptalis Pharmaceuticals, LLC at 1-833-727-8254 or FDA at 1­800-FDA-1088 or www.fda.gov/medwatch.

  • DOSAGE AND ADMINISTRATION

    Carefully remove all cerumen and debris to allow acetic acid otic solution to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with acetic acid otic solution into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 drops to 5 drops of acetic acid otic solution every 4 hours to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of acetic acid otic solution 3 times or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 drops to 4 drops may be sufficient due to the smaller capacity of the ear canal.

  • HOW SUPPLIED

    Acetic acid otic solution, USP, containing 2% acetic acid, is available in 15 mL measured‑drop, safety-tip plastic bottles. 

    NDC 52817-816-15    15 mL Bottle

  • STORAGE

    Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Keep container tightly closed.

    Manufactured by:

    Saptalis Pharmaceuticals, LLC

    Hauppauge, NY 11788

    Distributed by:

    TruPharma, LLC

    Tampa, FL 33609

    Rev. 03/20-R1

  • PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

    NDC 52817-816-15

    Acetic Acid Otic Solution
    USP, 2%

    Rx only

    15 mL

    Label

  • PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

    NDC 52817-816-15
    Acetic Acid Otic Solution
    USP, 2%

    Rx only

    15 mL

    Carton

  • INGREDIENTS AND APPEARANCE
    ACETIC ACID 
    acetic acid solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:52817-816
    Route of AdministrationAURICULAR (OTIC)
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ACETIC ACID (UNII: Q40Q9N063P) (ACETIC ACID - UNII:Q40Q9N063P) ACETIC ACID20.65 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    BENZETHONIUM CHLORIDE (UNII: PH41D05744)  
    PROPYLENE GLYCOL DIACETATE (UNII: 5Z492UNF9O)  
    SODIUM ACETATE (UNII: 4550K0SC9B)  
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:52817-816-151 in 1 CARTON06/05/2020
    115 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA04060706/05/2020
    Labeler - TruPharma, LLC (078533947)
    Registrant - Saptalis Pharmaceuticals, LLC (080145868)
    Establishment
    NameAddressID/FEIBusiness Operations
    Saptalis Pharmaceuticals, LLC081154447MANUFACTURE(52817-816)